357 GLS-010 (Zimberelimab), a novel fully human anti-PD-1 mAb in chinese patients with recurrent/metastatic cervical cancer: results from a multicenter, open-label, single-arm phase II trial

作者：Xiaohua Wu, Lingfang Xia, Qi Zhou, Jianqing Zhu, K Wang, J Chen, Yi Huang, Gulina Kurb, Baoping Chang, Weili Zhao, X Wang, Yanqing Yang, Zhongqiu Lin, X Luo, Ge Lou, C Wang, Jian Wang, Haijin Meng · 发表于：International Journal of Gynecological Cancer · 年份：2020 · DOI：10.1136/ijgc-2020-igcs.307 · 被引用次数：7 · 研究领域：Cancer Immunotherapy and Biomarkers、CAR-T cell therapy research、Cancer Research and Treatments